Both in vivo and in vitro experiments, including CCK‐8 assays, lipid peroxidation assays, iron measurements and ferroptosis‐related gene analyses, demonstrated that silencing FADS2 can trigger ferroptosis in bladder cancer cells. The gene discussed is FADS2; the disease is urinary bladder cancer.